Informed Prostate Cancer Patient Support

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT | Radiation Oncology | Full Text

Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer - International Journal of Radiation Oncology, Biology, Physics

Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples - Stover - - The Prostate - Wiley Online Library : Background Primary and metastatic prostate cancers have low mutation rates and recurrent alterations in a small set of genes, enabling targeted sequencing of prostate cancer-associated genes as an e...

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer | Prostate Cancer and Prostatic Diseases

New blood test combined with image-based prostate cancer screening reduces harms and costs -- ScienceDaily

Genetic Risk Score Prevents Unnecessary Prostate Cancer Workups

Prostate Cancer: a comparison of focal therapy and radical prostatectomy | Prostate Cancer and Prostatic Diseases

Genetic clues link lipoprotein A to prostate cancer risk: UK Biobank and other data identifies genetic variants linked to high lipoprotein A levels and high prostate cancer risk -- ScienceDaily

Breast cancer risk genes linked to prostate, pancreatic and stomach cancer

Some Beta Blockers Tied to Lower Recurrence Risk After Prostatectomy | MedPage Today

Robot performs first laparoscopic surgery without human help -- ScienceDaily

Faulty BRCA genes linked to prostate and pancreatic cancers -- ScienceDaily

Transcriptome subtyping of metastatic Castration Resistance Prostate Cancer (mCRPC) for the precision therapeutics: an in silico analysis | Prostate Cancer and Prostatic Diseases

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1) | Prostate Cancer and Prostatic Diseases

AI Holds Its Own vs Pathologists for Prostate Cancer Diagnosis

A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI | Prostate Cancer and Prostatic Diseases

Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases

Magnesium is essential for the immune system, including in the fight against cancer -- ScienceDaily

FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®

Meta-analysis may help guide treatment planning for patients with high-risk prostate cancer -- ScienceDaily : Results of a large study could help guide treatment planning for patients with high-risk prostate cancer.

Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression

We've Never Really Understood the Prostate | MedPage Today

Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression | Cooking with Kathy Man

Prostate cancer and prostatic diseases is “Your” journal | Prostate Cancer and Prostatic Diseases

Plasma IL‐6 and TNF‐α levels correlate significantly with grading changes in localized prostate cancer - Zhou - - The Prostate - Wiley Online Library

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling - Moll - - The Prostate - Wiley Online Library

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD | Prostate Cancer and Prostatic Diseases

Can Prostate Cancer Patients on AS Delay Surgery at Progression? | MedPage Today : Study suggests subset of men with biopsy progression can safely stay on surveillance

AI accurately diagnoses prostate cancer, study shows -- ScienceDaily

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning | Prostate Cancer and Prostatic Diseases

Oregon State University research suggests possibility of vaccine to prevent skin cancer | Oregon State University

Assessing Progression Risk in Cancer: Expression signatures may be useful for assessing greatest risk of progression in prostate and other cancers -- ScienceDaily : A molecular feature in prostate cancer, called endogenous retroviral (ERV) RNA, has been found to have prognostic value and also distinguish differences between men of African and European or Middle Eastern ancestry, according to a new study. The team also identified ERV expression signatures that may be useful for identifying prostate cancer patients at greatest risk of progression regardless of ancestry, which may also extend to progression in other cancers.

Patterns of Structural Variation Define Prostate Cancer Across Disease States | bioRxiv

Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be? - Cao - - The Prostate - Wiley Online Library

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from... - YouTube

Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics | Prostate Cancer and Prostatic Diseases

Declining Cancer Incidence in the Elderly: Decreasing Diagnostic Intensity or Biology? | Cancer Epidemiology, Biomarkers & Prevention

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort | Cancer Epidemiology, Biomarkers & Prevention

Assessing changes to N95 respirator filtration efficiency, qualitative and quantitative fit, and seal check with repeated vaporized hydrogen peroxide (VHP) decontamination - American Journal of Infection Control

Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics | Prostate Cancer and Prostatic Diseases

PSMA PET/CT Validated as Imaging Modality in Prostate Cancer

23andMe gets FDA clearance for prostate cancer risk test - The Verge theverge.com 23andMe gets FDA clearance for prostate cancer risk test Nicole Wetsman 3-4 minutes Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test, the company announced today . It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk. The test screens for a specific mutation on the HOXB13 gene linked with an increased risk of developing prostate cancer. Men with the mutation, the G84E variant, have around a three-fold higher chance of developing prostate cancer than men without, one study found. Around one in 70 people of European descent have the variant, according to a statement from 23andMe. The prostate cancer risk report is not yet available to 23andMe customer

Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study | Prostate Cancer and Prostatic Diseases

Prizing open the trap: Getting to grips with targeted cancer drug resistance.

Prostate cancer detection: a systematic review of urinary biosensors | Prostate Cancer and Prostatic Diseases

California Democrats Revive Universal Healthcare Bill medscape.com California Democrats Revive Universal Healthcare Bill Adam Beam, Associated Press 3-4 minutes SACRAMENTO, Calif. (AP) — What could be the nation's first universal health care system found new life on Thursday after California Democrats proposed steep tax hikes to pay for it, prompting strong opposition from insurers, doctors and Republicans at the start of an election year. Progressives in California's Democratic-dominated state Legislature have long called for a universal health care system to replace the one that mostly relies on private insurance companies. But their plans have often stalled over questions about how to pay for it in a state with nearly 40 million residents. Assemblyman Ash Kalra proposed an amendment to the state Constitution that would impose an annual tax of 2.3% on businesses that have at

Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition - Raspin - - The Prostate - Wiley Online Library

Prostate cancer detection: a systematic review of urinary biosensors | Prostate Cancer and Prostatic Diseases

Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients | Prostate Cancer and Prostatic Diseases

Portable prostate cancer test may help reach underserved men -- ScienceDaily : A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African American men.

Single‐port versus multiport robotic‐assisted radical prostatectomy: A systematic review and meta‐analysis on the da Vinci SP platform - Hinojosa‐Gonzalez - - The Prostate - Wiley Online Library

Pilot study of the diagnostic utility of 89Zr‐df‐IAB2M and 68Ga‐PSMA‐11 PET imaging and multiparametric MRI in localized prostate cancer - Vlachostergios - - The Prostate - Wiley Online Library

Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial | Prostate Cancer and Prostatic Diseases

Some Men With Localized Prostate Cancer Regret Surgery | Oncology | JAMA | JAMA Network

Black Men Get Better Outcomes From Radiation for Prostate Cancer

Patterns of prostate cancer recurrence after brachytherapy determined by PSMA PET/CT imaging - ScienceDirect

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging | Journal of Nuclear Medicine

The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer | Journal of Nuclear Medicine

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study | Journal of Nuclear Medicine

Drop in PSA Tied to Better Outcomes of Apalutamide Therapy in Prostate Cancer